There is no comprehensive evidence for use of HCQ for prophylaxis of COVID-19. Few studies with small sample and that too with flaws in research methodology are available. Most of the published research is available as pre-print and yet to be peer reviewed. Unproven use in millions of healthcare providers and other contacts of COVID-19 patients can lead to many adverse consequences and result in harm rather than any benefit (it has proven adverse effects but not proven benefit). Cardiac toxicity (QT prolongation and ventricular arrhythmia, risk is more when used along with azithromycin ), ocular toxicity, hypoglycemia and hemolysis in G6PD deficient subjects are big disadvantages. even if the incidence of such adverse effects are low but use in millions of people across the world can result into significant fatal outcomes. Provided the immunomodulatory role of HCQ, it can suppress immunity and during that period exposed individuals are likely to catch COVID-19, causing harm rather than any benefit. On the contrary, more sensible use of immunomodulatory role of HCQ will be in COVID-19 patients with severe pneumonia where the suppression of cytokines can prevent further damage. With this background, I strongly oppose its use in prophylaxis but I do agree with its use in COVID-19 patients with severe pneumonia to prevent the cytokine storm and further damage. Your views will be appreciated.

More Harmanjit Singh's questions See All
Similar questions and discussions